NRI Secure Launches Japan's First "Blockchain Assessment" Service
NRI SecureTechnologies, Ltd. (President: Jun Odashima; hereinafter NRI Secure), a leading provider of information security solutions in Japan, has begun providing Japan’s first-ever*1 “Blockchain Assessment,” a security Assessment service designed for systems and services which use blockchain technology*2.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170721005012/en/
Overview of the "Blockchain Assessment" Service (Graphic: Business Wire)
As the blockchain technology has become more widespread, the presence of security-related vulnerabilities has also become increasingly apparent. In particular, with regard to smart contracts, *3 one of a constituent element of services using the blockchain, a cyberattack carried out on any vulnerable programs could lead to major threats or even to actual damage*4 by causing services to behave differently than originally intended.
In response to these issues, NRI Secure has systematized its accumulated knowledge and insights in the form of the “Blockchain Assessment” service. As its first step, NRI Secure will be launching the security assessment service for smart contracts. The service performs assessment from the dual perspectives of static analysis, which carefully analyzes a program, and dynamic analysis, which involves simulating a real attack, in order to identify vulnerabilities.
More assessment menus for other constituent elements of the blockchain will be added in the future. (2 to 4 in the overview diagram). This service is only available in English and Japanese.
NRI Secure continues to provide a variety of products and services for supporting companies and organizations in their information security measures, and to contribute to the creation of a safe information system environment and society on a global scale.
|*1||First-ever in Japan: This is the first security assessment service designed specifically for the blockchain to be provided by a medium- or large-scale security vendor in Japan (according to NRI Secure research).|
|*2||Blockchain technology: A technology which achieves a distributed consensus among its participants and makes it possible to manage audit trails for all transactions, without the intervention of a trusted third party. Given such features as its ability to make falsifying data extremely difficult, its near-zero downtime, its lack of a centralized manager, and its high transaction performance, the blockchain has been lauded for being inexpensive to develop and for its potentially broad application as a way for companies to exchange information. These features have led to expectations that the blockchain can be used not only for cryptocurrencies such as Bitcoin, but as a circulation platform for transactions involving various asset types. Furthermore, this technology is also gaining notice for its potential use in the recording and storage of more common types of contracts, as well as in automatic contract execution.|
|*3||Smart contracts: This refers to contracts which are programmed and can be automatically executed. A smart contract is arranged with the execution conditions and contractual terms prescribed in advance, such that the contract is automatically executed when a transaction occurs matching said conditions. Smart contracts are being considered for use in securities settlements, real property transactions, the sharing economy, and numerous other fields that involve contracts.|
|*4||Actual damage: “The DAO Incident” occurred on June 17, 2016. Funds (virtual currency) held by “The DAO,” a virtual corporation established by a Germany-based venture capital company, were transmitted to a cyber-attacker who had exploited vulnerabilities in The DAO’s smart contract programming code.|
|*5||DApps: This abbreviation stands for Decentralized Applications, and refers to applications that are decentralized and distributed. They are said to enable the use of highly-reliably, low-cost applications via blockchain technology, without the need for a centralized system manager.|
About NRI Secure
NRI SecureTechnologies is a subsidiary of Nomura Research Institute
(NRI) specializing in Cybersecurity, and a leading global provider of
next-generation managed security services and security consulting.
Established in 2000, NRI SecureTechnologies is focused on delivering
high-value security outcomes for our clients with the precision and
efficiency that define Japanese quality.
For more details, visit us at http://www.nri-secure.com
“Blockchain Assessment” Service
Supported platforms: Ethereum, Hyperledger Fabric
*Additional platforms will be supported at a later time.
Supported languages: Solidity, Go, Java
*Please contact us regarding any other languages.
- Price: Estimates will be provided on an individual basis.
- For more details on the “Blockchain Assessment” Service, please contact: firstname.lastname@example.org.
NRI SecureTechnologies, Ltd.
Hitomi Nemoto, +81-3-6706-0622
NRI SecureTechnologies, Ltd.
Teruhiro Tagomori / Takenori Kiuchi, +81-3-6706-0622
Cyber Security Services Department II
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha